Blood test-guided surgery for gastroesophageal cancer
Part of Cancer, Digestive system clinical trials.
This trial studies blood-based biomarkers to help doctors choose the best individualized surgical treatment for gastroesophageal junction adenocarcinoma. If you qualify, you’ll get standard care plus additional testing to see whether the blood results can guide surgery more precisely.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have confirmed adenocarcinoma where the esophagus meets the stomach (GEJ), stage that has not spread to distant organs
- Your cancer can be removed with curative intent (it must be considered operable by the local surgeon)
- You are age 18 or older
- You are well enough to do daily activities (ECOG score 0 to 2)
- Your overall health for anesthesia is not too severe (ASA score under 4)
- You can sign consent and understand study procedures
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at using a blood test that finds tiny bits of cancer DNA to decide if you need extra chemotherapy after surgery. It aims to make treatment more personalized and reduce side effects for people with locally advanced stomach cancer.
This trial is testing whether using a blood test to find tiny amounts of cancer DNA after initial treatment can guide decisions about further therapy for people with stomach cancer. The goal is to personalize follow-up treatment to reduce the chance of cancer returning.
This study tests a new way to guide treatment after surgery for stomach cancer. It uses a blood test to look for tiny pieces of cancer DNA, and then gives extra treatment only to people who still have signs of cancer. The goal is to prevent the cancer from coming back.
This trial combines an experimental immunotherapy drug with standard chemotherapy before and after surgery for patients with a specific type of stomach-esophagus cancer. The goal is to see if this combination improves outcomes, including shrinking the tumor to make surgery more effective.
This study tracks a simple blood test to look for tiny traces of cancer DNA after stomach cancer surgery. It aims to see if this test can catch any cancer coming back early, so you can get treatment sooner.
This study uses special blood tests to detect cancer DNA and help doctors decide the best treatment plan for gastric cancer. The goal is to improve outcomes by personalizing therapy based on how your cancer responds.
Hear when a new Cancer of Esophagus trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.